Clover Corporation Limited

CLV

AU000000CLV2

Food Processing

Delayed Australian S.E. Other stock markets 21:50:15 2024-05-29 EDT			5-day change	1st Jan Change
0.505 ^AUD	0.00%		-0.98%	-38.79%

03-20	Clover Swings to Loss in H1 FY24; Shares Down 16%	MT
03-19	Clover Corporation Limited Reports Earnings Results for the Half Year Ended January 31, 2024	CI

Clover Corporation Limited Appoints Peter Davey as Director

December 16, 2014 at 01:28 am

Clover Corporation Limited announced on 11 November 2014 regarding the appointment of Mr. Peter Davey as Managing Director & CEO of the company, Mr. Davey was formally appointed by the Board as a Director of Clover on 16 December 2014.

Latest news about Clover Corporation Limited

Clover Swings to Loss in H1 FY24; Shares Down 16%	03-19	MT
Clover Corporation Limited Reports Earnings Results for the Half Year Ended January 31, 2024	03-19	CI
Clover Corporation Limited(ASX:CLV) dropped from S&P/ASX All Ordinaries Index	03-17	CI
Transcript : Clover Corporation Limited - Shareholder/Analyst Call	11-22
Clover Corporation Limited Declares Payment of Final Dividend for the Financial Year 2023	11-20	CI
Clover Corporation Limited Declares Fully Franked Final Dividend for the Financial Year Ended 31 July 2023, Payable on 20 November 2023	23-09-25	CI
Clover Corporation Limited Reports Earnings Results for the Full Year Ended July 31, 2023	23-09-25	CI
Clover Corporation Limited(ASX:CLV) dropped from S&P/ASX Emerging Companies Index	23-03-20	CI
Clover Corporation Limited Declares Fully Franked Final Dividend for First Half of Financial Year 2023, Payable on 27 April 2023	23-03-14	CI
Clover Corporation Limited Reports Earnings Results for the Half Year Ended January 31, 2023	23-03-14	CI
Clover Corporation Limited Reports Earnings Results for the Half Year Ended January 31, 2023	23-03-14	CI
Clover Corporation Seeks Mergers and Acquisitions	22-11-23	CI
Transcript : Clover Corporation Limited - Shareholder/Analyst Call	22-11-23
Clover Declares FY22 Final Dividend	22-11-21	MT
Clover Corporation Limited Payment of Final Dividend for the Financial Year 2022	22-11-21	CI
Clover Informs Study Results by the South Australian Health and Medical Research Institute	22-10-26	CI
Clover Corporation Limited Declares Fully Franked Final Dividend for the Year Ended 31 July 2022, Payable on 22 November 2022	22-10-18	CI
Clover Corporation Limited(ASX:CLV) dropped from S&P Global BMI Index	22-09-19	CI
UBS Upgrades Clover to Buy From Neutral, Adjusts Price Target to AU$1.35 From AU$1.40	22-09-16	MT
Clover's Net Profit After Tax Jumps 18.8% in FY22	22-09-14	MT
Clover Corporation Limited Reports Earnings Results for the Full Year Ended July 31, 2022	22-09-13	CI
Clover Improves Cognitive Development of Prematurely Born Children	22-03-21	MT
Clover Corporation Limited Announces the Release of New Results from the Clinical Research Study Called the N3RO Trial	22-03-20	CI
UBS Downgrades Clover to Neutral From Buy, Adjusts Price Target to AU$1.4 From AU$1.85	22-03-18	MT
Clover Records Lower Fiscal H1 Profit	22-03-16	MT

Chart Clover Corporation Limited

Duration

Period

More charts

Company Profile

Clover Corporation Limited is focused on technology, new product development and commercialization. The principal activities of the Company are the refining and sale of natural oils, the production of encapsulated powders and the research and product development of functional food and infant nutrition ingredients. The Companyâs microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formula, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company, through its subsidiary, Nu-Mega Ingredients Pty Limited (Nu-Mega), supplies refined Omega-3 oils and a range of other encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. Nu-Megaâs Driphorm range of microencapsulated powders enables the addition of Hi-DHA tuna and/or algal oils to a broad spectrum of products.

Sector

Food Processing

Calendar

2024-09-18 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Clover Corporation Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

0.505 AUD

Average target price

0.6 AUD

Spread / Average Target

+18.81%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
CLOVER CORPORATION LIMITED	-38.79%	56.73M
ZHEJIANG NHU COMPANY LTD.	+11.56%	8.18B
BELLRING BRANDS, INC.	+5.29%	7.53B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	-0.42%	5.89B
THE SIMPLY GOOD FOODS COMPANY	-7.20%	3.7B
BYHEALTH CO., LTD	-11.22%	3.57B
XIAMEN KINGDOMWAY GROUP COMPANY	-8.51%	1.26B
HERBALIFE LTD.	-32.83%	1.08B
SIRIO PHARMA CO., LTD.	+13.85%	991M
USANA HEALTH SCIENCES, INC.	-13.06%	894M

Special Foods & Wellbeing Products